WAO guideline for the management of hereditary angioedema

Timothy Craig, Emel Aygören Pürsün, Konrad Bork, Tom Bowen, Henrik Boysen, Henriette Farkas, Anete Grumach, Constance H. Katelaris, Richard Lockey, Hilary Longhurst, William Lumry, Markus Magerl, Immaculada Martinez-Saguer, Bruce Ritchie, Alexander Nast, Ruby Pawankar, Bruce Zuraw, Marcus Maurer

Research output: Contribution to journalArticlepeer-review

292 Scopus citations


Hereditary Angioedema (HAE) is a rare disease and for this reason proper diagnosis and appropriate therapy are often unknown or not available for physicians and other health care providers. For this reason we convened a group of specialists that focus upon HAE from around the world to develop not only a consensus on diagnosis and management of HAE, but to also provide evidence based grades, strength of evidence and classification for the consensus. Since both consensus and evidence grading were adhered to the document meets criteria as a guideline. The outcome of the guideline is to improve diagnosis and management of patients with HAE throughout the world and to help initiate uniform care and availability of therapies to all with the diagnosis no matter where the residence of the individual with HAE exists.

Original languageEnglish (US)
Pages (from-to)182-199
Number of pages18
JournalWorld Allergy Organization Journal
Issue number12
StatePublished - Dec 2012

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology
  • Pulmonary and Respiratory Medicine


Dive into the research topics of 'WAO guideline for the management of hereditary angioedema'. Together they form a unique fingerprint.

Cite this